Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Madrigal Pharmaceuticals, Inc.
About MDGL
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. The Company’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-b agonist designed to target key underlying causes of MASH. Rezdiffra is the medication approved by the United States Food and Drug Administration (FDA) for the treatment of MASH with moderate to advanced fibrosis (consistent with stages F2 to F3). Rezdiffra is a prescribed medicine used along with diet and exercise to treat adults with nonalcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver. An ongoing Phase III outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (consistent with stage F4c).
Find out what a historical investment in Madrigal Pharmaceuticals, Inc. would be worth today using our MDGL stock calculator.
Market Capitalisation
$11.80B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
361.11K
High today
$523.16
Low today
$499.34
Open price
$518.72
52-week high
$615.00
52-week low
$265.00
Ready to start your investing journey with Stake?
Open an accountHow do I buy MDGL shares in Australia?
Buying MDGL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Madrigal Pharmaceuticals, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in MDGL
What is the ticker symbol of Madrigal Pharmaceuticals, Inc.?
The ticker symbol for Madrigal Pharmaceuticals, Inc. is MDGL.
How much is one share of MDGL?
One share of MDGL is valued at $513.58 as of 21 May 2026.
What is the market capitalisation of Madrigal Pharmaceuticals, Inc. MDGL?
As of 21 May 2026 Madrigal Pharmaceuticals, Inc. has a market cap of $11.80B.
What is the 52-week high for Madrigal Pharmaceuticals, Inc. stock?
The Madrigal Pharmaceuticals, Inc. 52-week high stock price is $615.00.
What is the 52-week low for Madrigal Pharmaceuticals, Inc. stock?
The Madrigal Pharmaceuticals, Inc. 52-week low stock price is $265.00.
Can I buy MDGL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MDGL shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MDGL on Stake
- Buy MDGL from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of MDGL from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
MDGL related stocks